Format

Send to

Choose Destination
See comment in PubMed Commons below
GMHC Treat Issues. 1996 Aug;10(8):10.

More information on hydroxyurea.

Abstract

AIDS:

Franco Lori, director of the Research Institute for Genetic and Human Therapy (RIGHT), explains the results of the clinical trial of ddI versus ddI and hydroxyurea. Hydroxyurea shows a capacity to induce sustained viral inhibition when used in combination with ddI. The only adverse effect reported was hair loss. Several of the studies and their findings are reported, and other planned studies are described.

PMID:
11363717
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center